---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-238120"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:45:19.993329+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Crinetics COO James Hassard departs; consulting deal through Jan 2025 at $200/hr

## Summary
- James Hassard ceased as COO effective Oct 14, 2024; consulting and separation agreements signed Oct 10.
- Consulting agreement: up to 20 hrs/month at $200/hr through Jan 15, 2025 for commercial launch prep.
- Separation agreement provides payments/benefits for termination without cause per employment contract.
- Outstanding equity awards continue to vest through Jan 15, 2025; prior employment agreement terminated.

## SEC filing metadata
- accession: 0001193125-24-238120
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000119312524238120/0001193125-24-238120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000119312524238120/d850938d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-238120
- JSON: https://secwatch.observer/filing/0001193125-24-238120.json
- Plain text: https://secwatch.observer/filing/0001193125-24-238120.txt

## Key facts
- Executive change
  James Hassard departed as Chief Operating Officer at Crinetics Pharmaceuticals, Inc..
  - Action: ceased serving
  - Role: Chief Operating Officer
  source text: James Hassard ceased serving as the Chief Operating Officer of the Company, effective October 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1658247/000119312524238120/0001193125-24-238120-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.